This inventor holds 1 USPTO granted patent. Top assignee: Celgene Corporation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Fedor Romanov Michailidis: Innovator in Pharmaceutical Chemistry
Introduction
Fedor Romanov Michailidis is a notable inventor based in Ain, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.
Latest Patents
Fedor holds 1 patent for his invention titled "Thienopyridine inhibitors of RIPK2." This invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same. His work in this area showcases his commitment to advancing medical science.
Career Highlights
Fedor is currently employed at Celgene Corporation, a leading biopharmaceutical company. His role involves research and development, where he applies his expertise to create impactful pharmaceutical solutions.
Collaborations
Fedor has collaborated with esteemed colleagues, including Kurt Armbrust and Karin Irmgard Worm. These partnerships have enhanced his research and contributed to the success of his projects.
Conclusion
Fedor Romanov Michailidis exemplifies innovation in the pharmaceutical industry through his patent and collaborative efforts. His work continues to influence the development of new therapeutic compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile